Last reviewed · How we verify
NCT03689322
Effects of WBV Associated With IMT on Inflammatory Markers, Body Composition, Muscle Strength and Thickness
NA trial testing WBV + IMT in Frail Elderly Syndrome in 42 participants. Completed in 30 July 2019.
30 May 2019
Quick facts
| Lead sponsor | Universidade Federal de Pernambuco |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 42 |
| Start date | 1 October 2018 |
| Primary completion | 30 May 2019 |
| Estimated completion | 30 July 2019 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- WBV + IMT
- WBV + IMTsham
- WBVsham + IMTsham
Conditions studied
- Frail Elderly Syndrome — all drugs for Frail Elderly Syndrome →
Sponsor
Universidade Federal de Pernambuco — full company profile →
Who can join
Adults 60 to 80, female only, with Frail Elderly Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aging generates immune, muscular and functional changes. In the pre-frail elderly these changes may be increased and, therefore, preventive interventions are indicated to minimize the consequences of sarcopenia in this population. This study aims to evaluate the effects of a whole body vibration training associated with the training of inspiratory muscles on the inflammatory, muscular and body composition outcomes in pre-frail elderly women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03689322
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of WBV + IMT
Trials testing the same drug.
- NCT03688932 — Effects of WBV Associated With IMT on Functionality · NA · completed
Other recruiting trials for Frail Elderly Syndrome
Currently open trials in the same condition.
- NCT06857981 — Patient's Database: Prepare for Your Surgery Program · recruiting
- NCT06469437 — The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM · NA · recruiting
- NCT06444321 — INTEgRated Health CARE for Patients With Frailty and Heart Failure · NA · recruiting
- NCT05993754 — Non-pharmacological Prevention of POD in Frailty Elderly Undergoing Elective Surgery Applied by Nursing Teams · NA · recruiting
- NCT06496022 — Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome · active not recruiting
Other Universidade Federal de Pernambuco trials
Trials by the same sponsor.
- NCT07366411 — taVNS on Functional Mobility in People With DP · Phase 2 · not yet recruiting
- NCT07132021 — Efficacy of Trans-auricular Vagus Nerve Stimulation on Upper Extremity Motor Recovery in Stroke Survivors · Phase 2 · recruiting
- NCT07149233 — Effectiveness of Inspiratory Muscle Training on Sleep in Patients With Obstructive Sleep Apnea · NA · enrolling by invitation
- NCT06886386 — TsDCS and Physical Therapy After Incomplete Spinal Cord Injury · NA · enrolling by invitation
- NCT07523126 — EFFECT OF TRANSCUTANEOUS ELECTRONEURO-STIMULATION OF THE VAGUS NERVE ON JOINT PAIN SEQUELAE OF CHIKUNGUNYA FEVER IN THE · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03689322 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal de Pernambuco
- Last refreshed: 25 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03689322.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing